$XALL is taking a high value position in the worldwide

New Post Public Reply Private Reply Replies (0) Message Board
Lee Adams
135
$XALL is taking a high value position in the worldwide Metadata and Artificial Intelligence solutions field with its recent acquisition.

Xalles Enters Global Metadata Management Solutions Business with Adaptive Acquisition

WASHINGTON, DC, July 21, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Xalles Holdings Inc. (OTC: XALL), a Fintech holding company providing technology and financial services solutions, today announces that it has executed a Share Exchange Agreement to acquire 100% of Adaptive Metadata Solutions Inc. (“Adaptive”). Adaptive Metadata Solutions is a Master Reseller of Adaptive products and provides industry leading metadata analytics (data that describes other data), and artificial intelligence solutions to large enterprises.

Adaptive provides Fortune 500 clients with essential software solutions that deliver a business discipline of data governance, control and innovation to the enterprise. Industries currently serviced include Insurance, Financial Services, Government Agencies, Healthcare, Energy, and many other regulated industries, where compliance and data governance are critical to operational and strategic success. Adaptive is projected to generate at least $5 million in 2020 revenue and more than $10 million in revenue in 2021.

Collectively, Adaptive’s product suite is used by clients that include Bank of America, Federal Reserve Bank of New York, Western Union, the U.S. Government’s General Accounting Office (GAO), Dell, United Natural Foods, and numerous central banks and financial services companies. The cloud based or on-premises Adaptive platform enables organizations to understand the entire data landscape of an enterprise providing end-to-end data lineage analytics. Gartner named Adaptive’s platform as a Leader in its 2019 Magic Quadrant for Metadata Management Solutions. Clients leverage the Adaptive platform for enhanced data governance, analytics, Artificial Intelligence and Machine Learning best practices and reuse.

Adaptive Metadata Solutions Inc. is led by its CEO, Eric Reehl. Mr. Reehl has over 25 years of experience as an investor and advisor to companies, lenders, and investors across a range of industries for both debt and equity capital. He has led in excess of $5 billion of direct investments and restructurings as a principal or advisor. He previously served as a Managing Director for Plainfield Asset Management LLC, a $5.2 billion Greenwich, Connecticut-based hedge fund. He received his Master’s Degree in Business and undergraduate degree from the University of Texas at Austin.

Adaptive’s CEO commented, “The Adaptive and Xalles relationship will facilitate our growth in multiple vertical markets to build upon our successful client implementations. Adaptive is perfectly positioned for rapid global growth in the next 2 years through our alliances and channel partners, which account for a significant number of our business referrals.”

“The Adaptive acquisition is the definition of synergy. Adaptive will add value to our existing operating companies and technologies, while Argus Technology Partners will expand Adaptive’s reach into new vertical markets,” stated Thomas Nash, Xalles Holdings CEO. “We have a unique opportunity to cross sell our products between companies. Adaptive’s offerings will create additional opportunities that will enable our client base to achieve tremendous savings and compliance benefits through data analytics, and artificial intelligence to support governance applications and cyber security. The real value proposition of this acquisition to our shareholders comes in the form of building a recurring revenue stream with a growing base of blue chip clientele as we complete our current fundraising effort.”

Xalles Technology Inc., a wholly owned subsidiary of Xalles Holdings Inc., will acquire all of the shares of Adaptive Metadata Solutions Inc., making Adaptive a wholly owned subsidiary of Xalles Technology. The acquisition agreement defines the closing date for this transaction as on or before August 10, 2020.

About Xalles Holdings Inc. (OTC: XALL)

Xalles Holdings Inc. is a holding company that focuses on acquisition and support of disruptive fintech companies. The company actively seeks targets in which it can partner with or acquire to accelerate growth, targeting companies with solid management teams and business models, large total attainable markets (TAM), and lucrative exit opportunities. The company places an emphasis on leveraging blockchain technologies to provide industry-leading financial reconciliation and auditing solutions, which, over time, will allow for the capture of recurring revenue streams. For more information visit: http://Xalles.com

About Adaptive

Adaptive Metadata Solutions Inc. is headquartered in Dallas, Texas. The Adaptive platform was named by Gartner as a leader in the 2019 Magic Quadrant for Metadata Management Solutions along with Oracle, IBM, Infomatica, and SAP. Adaptive is a market leader with a long history of helping simplify the complex data that organizations generate by adapting and eliminating the time consuming and expensive tasks of managing corporate information. The company’s offerings are designed to support the rapidly changing business and IT environments, which are driven by the ever increasing demands of compliance, regulatory pressures and governance requirements. Adaptive provides innovative solutions that enable enterprises to align their capabilities with strategic intent. Adaptive offers standards-based solutions that help organizations better align their valuable information by supporting specific management challenges including Data Governance, Data Quality, Metadata Management, Enterprise Architecture Management and IT Portfolio Management while ensuring Knowledge is retained as systems evolve. For more on the Adaptive product suite, visit http://www.adaptive.com

Forward-Looking Statements Disclaimer:

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainty and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are contained in the Edgar Archives of the Securities and Exchange Commission at www.sec.gov and in OTC Markets at www.otcmarkets.com

Investor Relations Contact:

Info@Xalles.com

www.Xalles.com

202.595.1299 Office

Corporate Communications:

NetworkNewsWire (NNW)

New York, New York

www.NetworkNewsWire.com

212.418.1217 Office

Editor@NetworkWire.com




















Scroll down for more posts ▼

Top 10 Most Recent News Articles

Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 159

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 92

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 118

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 158

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 98

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 0

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 201

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 0

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading

Top 5 Most Recently Viewed Articles

Spruce Point's Strong Sell Rating Casts Doubt on Construction Partners

Updated Category News Views 116

Spruce Point's Strong Sell Opinion on Construction Partners Inc Spruce Point Capital Management has recently issued a compelling report regarding Construction Partners Inc (NASDAQ: ROAD), a company recognized for its expertise in infrastructure and road construction. This report voices a strong sell recommendation, reflecting serious concerns over the company's current...

Continue Reading
Celebrating Excellence in Healthcare: Press Ganey's Honorees

Updated Category News Views 344

Celebrating the Executive Human Experience Award Winners Press Ganey, an industry leader dedicated to enhancing healthcare experiences, recently celebrated exceptional achievements in the field. During its annual conference, the Executive Human Experience Awards recognized extraordinary contributions from professionals and organizations that prioritize patient, consumer,...

Continue Reading
Commercial Vehicle Market Growth Driven by Technology Advancements

Updated Category News Views 122

Commercial Vehicle Market Growth and Projections The global commercial vehicle market is on an upward trajectory, with sales expected to reach 3.5 million units by 2025. The anticipated Year-over-Year (YoY) growth of 4.4% from 2024 highlights the increasing demand for medium and heavy commercial vehicles. This trend is being driven by several factors, including...

Continue Reading
Atos Receives Prestigious EcoVadis Platinum Medal Again

Updated Category News Views 195

Let’s not beat around the bush—Atos is doing something right in the sustainability game. They've bagged the EcoVadis Platinum Medal for five years running. Yep, that’s a serious flex in today’s corporate climate where ‘green’ isn’t just a buzzword; it’s almost an obligation if you want to stay relevant. The Metrics Behind Atos's Shine Scoring a...

Continue Reading
Power Metallic Mines Updates Shareholder Meeting Outcomes

Updated Category News Views 157

Power Metallic Mines Reports on AGSM Meeting Outcomes Power Metallic Mines Inc. (the "Company" or "Power Metallic") (TSXV: PNPN) (OTCBB: PNPNF) expressed satisfaction with the voting outcomes from its Annual General and Special Meeting ("AGSM") that took place recently. The meeting gathered shareholders to discuss essential business items and elect members to the Board of...

Continue Reading